Global Postoperative Pain Therapeutics Market: Industry Analysis and forecast (2019 to 2026): By Type, Organ System, Indication, End Users, and Region

Global Postoperative Pain Therapeutics Market was valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2026, at CAGR of 5.1 % during forecast period of 2019 to 2026. Global Postoperative Pain Therapeutics Market To know about the Research Methodology :- Request Free Sample Report The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis. Postoperative pain is defined as a condition of tissue injury together with muscle spasm after surgery. Recently, peripheral and central sensitization has been shown within the mechanisms of postoperative pain generation.

Global Postoperative Pain Therapeutics Market Drivers and Restrains

The changing lifestyle choices such as cosmetic reconstruction and plastic surgery are boosting the postoperative pain management market. Continuous efforts by the manufacturers to develop new non-opioid drugs for global postoperative pain management market is anticipated to fuel competition in the manufactures of postoperative pain management drugs. The increasing population and awareness about the surgical treatments in cancer and other chronic diseases such as chronic obstructive pulmonary disorder (COPD) is expected to propell the demand for postoperative pain management market.The changing healthcare scenario because of technological advances consequently propel the demand for postoperative pain management globally. Cancer treatment procedures involving mastectomy or lumpectomy require high dosage of postoperative pain management drugs. This will help to fuel the Global Postoperative Pain Therapeutics Market in forecast period.The patient’s undergone surgery required to be treated postoperative pain management drugs. The increasing number of surgical procedures and surgical interventions in various disease conditions is expected to create immense growth opportunities for the postoperative pain management market.

Global Postoperative Pain Therapeutics Market key segmentation

Opioids are the drugs recommended by doctors to treat moderate to severe chronic pain. Opioids can be classified into three major categories strong agonists (fentanyl, oxymorphone, and morphine), mild-to-moderate agonists (codeine and hydroxycodone), and opioids with mixed receptor reactions (buprenophrine and pentazocine). Local anthetics only provide limited pain relief frequently carry black box safety warnings and are susceptible to abuse. On the other hand the opioid misuse problem is described as a growing 'deadly epidemic' and a 'national emergency'. Novel technologies introduce safe therapies that treat various types of pain. An increase in the incidences of opioid drug abuse due to addiction, and production shortage of opioids as reported by Pfizer, are projected to hinder the growth of the postoperative pain therapeutics market in the forecast period.

Global Postoperative Pain Therapeutics Market Regional Analysis

North America highest share for global post-operative pain management market owing to increasing number of surgeries and rising burden of chronic diseases is responsible for this market growth in North America. Europe is the second largest post-operative pain management market thanks to well-developed healthcare infrastructure, government support for research & development. Asia Pacific is the fastest growing region for the market because of increasing prevalence of many diseases, huge aging population and development in healthcare infrastructure in this region has boosted market. The Middle East dominates the Middle East & Africa market due to the presence of well developed countries like Kuwait, Qatar, Oman and South Arabia. On the other hand, Africa region is expecting a healthy growth due to presence of opportunity for the development of the market. The objective of the report is to present comprehensive analysis of Global Postoperative Pain Therapeutics Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Postoperative Pain Therapeutics Market dynamics, structure by analyzing the market segments, and project the Global Postoperative Pain Therapeutics Market size. Clear representation of competitive analysis of key players by Postoperative Pain Therapeutics Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Postoperative Pain Therapeutics Market make the report investor’s guide.

Scope o the Global Postoperative Pain Therapeutics Market: Inquire before buying

Global Postoperative Pain Therapeutics Market by drug class

• Opioids • NSAIDS • Local Anaesthetics • Tricyclic Antidepressants • Antiepileptic Drugs

Global Postoperative Pain Therapeutics Market by distribution channel

• Hospital Pharmacies • Retail Pharmacies • Online Pharmacies

Key players operating on Global Postoperative Pain Therapeutics Market by region

• Mallinckrodt Pharmaceuticals, • Pacira BioSciences, • Trevena, • Heron Therapeutics, • Pfizer, • Teva Pharmaceutical Industries, • Novartis, • Camarus, • Eli Lilly, • Abbvie INc. • Acelrx Pharmaceuticals Inc. • Adynn • Alder Biopharmaceuticals Inc. • Allergan PLC • Astellas Pharmaceuticals Inc. • Axsome Therapeutics Inc. • Biohaven Pharmaceuticals Holding Company Ltd. • Biogen Inc. • Calchan Ltd. • Centrexion Therapeutics Corp. • Daiichi Sankyo Company Ltd. • Durect Corporation • Egalet Corporation • Galapagos NV • Genentech Inc. • Gilead Sciences Inc. • Heron Therapeutics • Immune Pharmaceuticals • Innovative Med Concepts Inc. • Intelipharmaceutics International Inc. • Lumosa Therapeutics Co. Ltd. • Meiji Seka Pharma Co. Ltd. • Mesoblast Ltd. • Nektar Therapeutics  
Global Postoperative Pain Therapeutics Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Postoperative Pain Therapeutics Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 4.8. Patent Registration 5. Supply Side and Demand Side Indicators 6. Global Postoperative Pain Therapeutics Market Analysis and Forecast 6.1. Global Postoperative Pain Therapeutics Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Postoperative Pain Therapeutics Market Analysis and Forecast, By Distribution channel 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Postoperative Pain Therapeutics Market Value Share Analysis, By Distribution channel 7.4. Global Postoperative Pain Therapeutics Market Size (US$ Bn) Forecast, By Distribution channel 7.5. Global Postoperative Pain Therapeutics Market Analysis, By Distribution channel 7.6. Global Postoperative Pain Therapeutics Market Attractiveness Analysis, By Distribution channel 8. Global Postoperative Pain Therapeutics Market Analysis and Forecast, By Drug class 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Postoperative Pain Therapeutics Market Value Share Analysis, By Drug class 8.4. Global Postoperative Pain Therapeutics Market Size (US$ Bn) Forecast, By Drug class 8.5. Global Postoperative Pain Therapeutics Market Analysis, By Drug class 8.6. Global Postoperative Pain Therapeutics Market Attractiveness Analysis, By Drug class 9. Global Postoperative Pain Therapeutics Market Analysis, by Region 9.1. Global Postoperative Pain Therapeutics Market Value Share Analysis, by Region 9.2. Global Postoperative Pain Therapeutics Market Size (US$ Bn) Forecast, by Region 9.3. Global Postoperative Pain Therapeutics Market Attractiveness Analysis, by Region 10. North America Postoperative Pain Therapeutics Market Analysis 10.1. Key Findings 10.2. North America Postoperative Pain Therapeutics Market Overview 10.3. North America Postoperative Pain Therapeutics Market Value Share Analysis, By Distribution channel 10.4. North America Postoperative Pain Therapeutics Market Forecast, By Distribution channel 10.4.1. Hospital Pharmacies 10.4.2. Retail Pharmacies 10.4.3. Online Pharmacies 10.5. North America Postoperative Pain Therapeutics Market Value Share Analysis, By Drug class 10.6. North America Postoperative Pain Therapeutics Market Forecast, By Drug class 10.6.1. Opioids 10.6.2. NSAIDS 10.6.3. Local Anaesthetics 10.6.4. Tricyclic Antidepressants 10.6.5. Antiepileptic Drugsl 10.7. North America Postoperative Pain TherapeuticsMarket Value Share Analysis, by Country 10.8. North America Postoperative Pain Therapeutics Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Postoperative Pain Therapeutics Market Analysis, by Country 10.10. U.S. Postoperative Pain Therapeutics Market Forecast, By Distribution channel 10.10.1. Hospital Pharmacies 10.10.2. Retail Pharmacies 10.10.3. Online Pharmacies 10.11. U.S. Postoperative Pain Therapeutics Market Forecast, By Drug class 10.11.1. Opioids 10.11.2. NSAIDS 10.11.3. Local Anaesthetics 10.11.4. Tricyclic Antidepressants 10.11.5. Antiepileptic Drugs 10.12. Canada Postoperative Pain Therapeutics Market Forecast, By Distribution channel 10.12.1. Hospital Pharmacies 10.12.2. Retail Pharmacies 10.12.3. Online Pharmacies 10.13. Canada Postoperative Pain Therapeutics Market Forecast, By Drug class 10.13.1. Opioids 10.13.2. NSAIDS 10.13.3. Local Anaesthetics 10.13.4. Tricyclic Antidepressants 10.13.5. Antiepileptic Drugsl 10.14. North America Postoperative Pain TherapeuticsMarket Attractiveness Analysis 10.14.1. By Distribution channel 10.14.2. By Drug class 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Development 11. Europe Postoperative Pain Therapeutics Market Analysis 11.1. Key Findings 11.2. Europe Postoperative Pain Therapeutics Market Overview 11.3. Europe Postoperative Pain Therapeutics Market Value Share Analysis, By Distribution channel 11.4. Europe Postoperative Pain Therapeutics Market Forecast, By Distribution channel 11.4.1. Hospital Pharmacies 11.4.2. Retail Pharmacies 11.4.3. Online Pharmacies 11.5. Europe Postoperative Pain Therapeutics Market Value Share Analysis, By Drug class 11.6. Europe Postoperative Pain Therapeutics Market Forecast, By Drug class 11.6.1. Opioids 11.6.2. NSAIDS 11.6.3. Local Anaesthetics 11.6.4. Tricyclic Antidepressants 11.6.5. Antiepileptic Drugs 11.7. Europe Postoperative Pain Therapeutics Market Value Share Analysis, by Country 11.8. Europe Postoperative Pain Therapeutics Market Forecast, by Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Postoperative Pain Therapeutics Market Analysis, by Country 11.10. Germany Postoperative Pain Therapeutics Market Forecast, By Distribution channel 11.10.1. Hospital Pharmacies 11.10.2. Retail Pharmacies 11.10.3. Online Pharmacies 11.11. Germany Postoperative Pain Therapeutics Market Forecast, By Drug class 11.11.1. Opioids 11.11.2. NSAIDS 11.11.3. Local Anaesthetics 11.11.4. Tricyclic Antidepressants 11.11.5. Antiepileptic Drugs 11.12. U.K. Postoperative Pain Therapeutics Market Forecast, By Distribution channel 11.12.1. Hospital Pharmacies 11.12.2. Retail Pharmacies 11.12.3. Online Pharmacies 11.13. U.K. Postoperative Pain Therapeutics Market Forecast, By Drug class 11.13.1. Opioids 11.13.2. NSAIDS 11.13.3. Local Anaesthetics 11.13.4. Tricyclic Antidepressants 11.13.5. Antiepileptic Drugs 11.14. France Postoperative Pain Therapeutics Market Forecast, By Distribution channel 11.14.1. Hospital Pharmacies 11.14.2. Retail Pharmacies 11.14.3. Online Pharmacies 11.15. France Postoperative Pain Therapeutics Market Forecast, By Drug class 11.15.1. Opioids 11.15.2. NSAIDS 11.15.3. Local Anaesthetics 11.15.4. Tricyclic Antidepressants 11.15.5. Antiepileptic Drugs 11.16. Italy Postoperative Pain Therapeutics Market Forecast, By Distribution channel 11.16.1. Hospital Pharmacies 11.16.2. Retail Pharmacies 11.16.3. Online Pharmacies 11.17. Italy Postoperative Pain Therapeutics Market Forecast, By Drug class 11.17.1. Opioids 11.17.2. NSAIDS 11.17.3. Local Anaesthetics 11.17.4. Tricyclic Antidepressants 11.17.5. Antiepileptic Drugs 11.18. Spain Postoperative Pain Therapeutics Market Forecast, By Distribution channel 11.18.1. Hospital Pharmacies 11.18.2. Retail Pharmacies 11.18.3. Online Pharmacies 11.19. Spain Postoperative Pain Therapeutics Market Forecast, By Drug class 11.19.1. Opioids 11.19.2. NSAIDS 11.19.3. Local Anaesthetics 11.19.4. Tricyclic Antidepressants 11.19.5. Antiepileptic Drugs 11.20. Rest of Europe Postoperative Pain Therapeutics Market Forecast, By Distribution channel 11.20.1. Hospital Pharmacies 11.20.2. Retail Pharmacies 11.20.3. Online Pharmacies 11.21. Rest of Europe Postoperative Pain Therapeutics Market Forecast, By Drug class 11.21.1. Opioids 11.21.2. NSAIDS 11.21.3. Local Anaesthetics 11.21.4. Tricyclic Antidepressants 11.21.5. Antiepileptic Drugs 11.22. Europe Postoperative Pain Therapeutics Market Attractiveness Analysis 11.22.1. By Distribution channel 11.22.2. By Drug class 11.23. PEST Analysis 11.24. Key Trend 11.25. Key Development 12. Asia Pacific Postoperative Pain Therapeutics Market Analysis 12.1. Key Findings 12.2. Asia Pacific Postoperative Pain Therapeutics Market Overview 12.3. Asia Pacific Postoperative Pain Therapeutics Market Value Share Analysis, By Distribution channel 12.4. Asia Pacific Postoperative Pain Therapeutics Market Forecast, By Distribution channel 12.4.1. Hospital Pharmacies 12.4.2. Retail Pharmacies 12.4.3. Online Pharmacies 12.5. Asia Pacific Postoperative Pain Therapeutics Market Value Share Analysis, By Drug class 12.6. Asia Pacific Postoperative Pain Therapeutics Market Forecast, By Drug class 12.6.1. Opioids 12.6.2. NSAIDS 12.6.3. Local Anaesthetics 12.6.4. Tricyclic Antidepressants 12.6.5. Antiepileptic Drugs 12.7. Asia Pacific Postoperative Pain Therapeutics Market Value Share Analysis, by Country 12.8. Asia Pacific Postoperative Pain Therapeutics Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Postoperative Pain Therapeutics Market Analysis, by Country 12.10. China Postoperative Pain Therapeutics Market Forecast, By Distribution channel 12.10.1. Hospital Pharmacies 12.10.2. Retail Pharmacies 12.10.3. Online Pharmacies 12.11. China Postoperative Pain Therapeutics Market Forecast, By Drug class 12.11.1. Opioids 12.11.2. NSAIDS 12.11.3. Local Anaesthetics 12.11.4. Tricyclic Antidepressants 12.11.5. Antiepileptic Drugs 12.12. India Postoperative Pain Therapeutics Market Forecast, By Distribution channel 12.12.1. Hospital Pharmacies 12.12.2. Retail Pharmacies 12.12.3. Online Pharmacies 12.13. India Postoperative Pain Therapeutics Market Forecast, By Drug class 12.13.1. Opioids 12.13.2. NSAIDS 12.13.3. Local Anaesthetics 12.13.4. Tricyclic Antidepressants 12.13.5. Antiepileptic Drugs 12.14. Japan Postoperative Pain Therapeutics Market Forecast, By Distribution channel 12.14.1. Hospital Pharmacies 12.14.2. Retail Pharmacies 12.14.3. Online Pharmacies 12.15. Japan Postoperative Pain Therapeutics Market Forecast, By Drug class 12.15.1. Opioids 12.15.2. NSAIDS 12.15.3. Local Anaesthetics 12.15.4. Tricyclic Antidepressants 12.15.5. Antiepileptic Drugs 12.16. ASEAN Postoperative Pain Therapeutics Market Forecast, By Distribution channel 12.16.1. Hospital Pharmacies 12.16.2. Retail Pharmacies 12.16.3. Online Pharmacies 12.17. ASEAN Postoperative Pain Therapeutics Market Forecast, By Drug class 12.17.1. Opioids 12.17.2. NSAIDS 12.17.3. Local Anaesthetics 12.17.4. Tricyclic Antidepressants 12.17.5. Antiepileptic DrugsCommercial 12.18. Rest of Asia Pacific Postoperative Pain TherapeuticsMarket Forecast, By Distribution channel 12.18.1. Hospital Pharmacies 12.18.2. Retail Pharmacies 12.18.3. Online Pharmacies 12.19. Rest of Asia Pacific Postoperative Pain Therapeutics Market Forecast, By Drug class 12.19.1. Opioids 12.19.2. NSAIDS 12.19.3. Local Anaesthetics 12.19.4. Tricyclic Antidepressants 12.19.5. Antiepileptic Drugs 12.20. Asia Pacific Postoperative Pain Therapeutics Market Attractiveness Analysis 12.20.1. By Distribution channel 12.20.2. By Drug class 12.21. PEST Analysis 12.22. Key Trend 12.23. Key Development 13. Middle East & Africa Postoperative Pain Therapeutics Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Postoperative Pain Therapeutics Market Overview 13.3. Middle East & Africa Postoperative Pain Therapeutics Market Value Share Analysis, By Distribution channel 13.4. Middle East & Africa Postoperative Pain Therapeutics Market Forecast, By Distribution channel 13.4.1. Hospital Pharmacies 13.4.2. Retail Pharmacies 13.4.3. Online Pharmacies 13.5. Middle East & Africa Postoperative Pain Therapeutics Market Value Share Analysis, By Drug class 13.6. Middle East & Africa Postoperative Pain Therapeutics Market Forecast, By Drug class 13.6.1. Opioids 13.6.2. NSAIDS 13.6.3. Local Anaesthetics 13.6.4. Tricyclic Antidepressants 13.6.5. Antiepileptic Drugs 13.7. Middle East & Africa Postoperative Pain Therapeutics Market Value Share Analysis, by Country 13.8. Middle East & Africa Postoperative Pain Therapeutics Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Postoperative Pain Therapeutics Market Analysis, by Country 13.10. GCC Postoperative Pain Therapeutics Market Forecast, By Distribution channel 13.10.1. Hospital Pharmacies 13.10.2. Retail Pharmacies 13.10.3. Online Pharmacies 13.11. GCC Postoperative Pain Therapeutics Market Forecast, By Drug class 13.11.1. Opioids 13.11.2. NSAIDS 13.11.3. Local Anaesthetics 13.11.4. Tricyclic Antidepressants 13.11.5. Antiepileptic Drugs 13.12. South Africa Postoperative Pain Therapeutics Market Forecast, By Distribution channel 13.12.1. Hospital Pharmacies 13.12.2. Retail Pharmacies 13.12.3. Online Pharmacies 13.13. South Africa Postoperative Pain Therapeutics Market Forecast, By Drug class 13.13.1. Opioids 13.13.2. NSAIDS 13.13.3. Local Anaesthetics 13.13.4. Tricyclic Antidepressants 13.13.5. Antiepileptic Drugs 13.14. Rest of Middle East & Africa Postoperative Pain Therapeutics Market Forecast, By Distribution channel 13.14.1. Hospital Pharmacies 13.14.2. Retail Pharmacies 13.14.3. Online Pharmacies 13.15. Rest of Middle East & Africa Postoperative Pain Therapeutics Market Forecast, By Drug class 13.15.1. Opioids 13.15.2. NSAIDS 13.15.3. Local Anaesthetics 13.15.4. Tricyclic Antidepressants 13.15.5. Antiepileptic Drugs 13.16. Middle East & Africa Postoperative Pain Therapeutics Market Attractiveness Analysis 13.16.1. By Distribution channel 13.16.2. By Drug class 13.17. PEST Analysis 13.18. Key Trend 13.19. Key Development 14. South America Postoperative Pain Therapeutics Market Analysis 14.1. Key Findings 14.2. South America Postoperative Pain Therapeutics Market Overview 14.3. South America Postoperative Pain Therapeutics Market Value Share Analysis, By Distribution channel 14.4. South America Postoperative Pain Therapeutics Market Forecast, By Distribution channel 14.4.1. Hospital Pharmacies 14.4.2. Retail Pharmacies 14.4.3. Online Pharmacies 14.5. South America Postoperative Pain Therapeutics Market Value Share Analysis, By Drug class 14.6. South America Postoperative Pain Therapeutics Market Forecast, By Drug class 14.6.1. Opioids 14.6.2. NSAIDS 14.6.3. Local Anaesthetics 14.6.4. Tricyclic Antidepressants 14.6.5. Antiepileptic Drugs 14.7. South America Postoperative Pain Therapeutics Market Value Share Analysis, by Country 14.8. South America Postoperative Pain Therapeutics Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. Brazil Postoperative Pain Therapeutics Market Forecast, By Distribution channel 14.9.1. Hospital Pharmacies 14.9.2. Retail Pharmacies 14.9.3. Online Pharmacies 14.10. Brazil Postoperative Pain Therapeutics Market Forecast, By Drug class 14.10.1. Opioids 14.10.2. NSAIDS 14.10.3. Local Anaesthetics 14.10.4. Tricyclic Antidepressants 14.10.5. Antiepileptic Drugs 14.11. Mexico Postoperative Pain Therapeutics Market Forecast, By Distribution channel 14.11.1. Hospital Pharmacies 14.11.2. Retail Pharmacies 14.11.3. Online Pharmacies 14.12. Mexico Postoperative Pain Therapeutics Market Forecast, By Drug class 14.12.1. Opioids 14.12.2. NSAIDS 14.12.3. Local Anaesthetics 14.12.4. Tricyclic Antidepressants 14.12.5. Antiepileptic Drugs 14.13. Rest of South America Postoperative Pain Therapeutics Market Forecast, By Distribution channel 14.13.1. Hospital Pharmacies 14.13.2. Retail Pharmacies 14.13.3. Online Pharmacies 14.14. Rest of South America Postoperative Pain Therapeutics Market Forecast, By Drug class 14.14.1. Opioids 14.14.2. NSAIDS 14.14.3. Local Anaesthetics 14.14.4. Tricyclic Antidepressants 14.14.5. Antiepileptic Drugs 14.15. South America Postoperative Pain Therapeutics Market Attractiveness Analysis 14.15.1. By Distribution channel 14.15.2. By Drug class 14.16. PEST Analysis 14.17. Key Trend 14.18. Key Development 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 15.2.2. New Distribution channel Launches and Distribution channel Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Applications 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Camarus, 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Distribution channel Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Company Footprint 15.3.2. Eli Lilly, 15.3.3. Bayer AG 15.3.4. Abbvie INc. 15.3.5. Acelrx Pharmaceuticals Inc. 15.3.6. Adynn 15.3.7. Alder Biopharmaceuticals Inc. 15.3.8. Allergan PLC 15.3.9. Astellas Pharmaceuticals Inc. 15.3.10. Axsome Therapeutics Inc. 15.3.11. Biohaven Pharmaceuticals Holding Company Ltd. 15.3.12. Biogen Inc. 15.3.13. Calchan Ltd. 15.3.14. Centrexion Therapeutics Corp. 15.3.15. Daiichi Sankyo Company Ltd. 15.3.16. Durect Corporation 15.3.17. Egalet Corporation 15.3.18. Galapagos NV 15.3.19. Genentech Inc. 15.3.20. Gilead Sciences Inc. 15.3.21. Heron Therapeutics 15.3.22. Immune Pharmaceuticals 15.3.23. Innovative Med Concepts Inc. 15.3.24. Intelipharmaceutics International Inc. 15.3.25. Lumosa Therapeutics Co. Ltd. 15.3.26. Meiji Seka Pharma Co. Ltd. 15.3.27. Mesoblast Ltd. 15.3.28. Nektar Therapeutics 16. Primary Key Insights

About This Report

Report ID 36191
Category Healthcare
Published Date Nov 2019
Updated Date Nov 2020
Contact Us